Juno Therapeutics (JUNO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2014 | 12-2013 | |
| Cash Flows From Operating Activities | ||
| Net Income | -8,949 | -51,820 |
| Depreciation Amortization | N/A | 2 |
| Accounts payable and accrued liabilities | 332 | 0 |
| Other Working Capital | -1,652 | 10,800 |
| Other Operating Activity | 680 | 10,508 |
| Operating Cash Flow | $-9,589 | $-30,510 |
| Cash Flows From Investing Activities | ||
| Change In Deposits | -3,455 | 0 |
| PPE Investments | -221 | -40 |
| Investing Cash Flow | $-3,676 | $-40 |
| Cash Flows From Financing Activities | ||
| Other Financing Activity | 0 | 66,510 |
| Financing Cash Flow | $N/A | $66,510 |
| Beginning Cash Position | 35,966 | 0 |
| End Cash Position | 22,701 | 35,960 |
| Net Cash Flow | $-13,265 | $35,960 |
| Free Cash Flow | ||
| Operating Cash Flow | -9,589 | -30,510 |
| Capital Expenditure | -221 | 0 |
| Free Cash Flow | -9,810 | -30,510 |